New approach for treating idiopathic pulmonary fibrosis
Researchers at Helmholtz Zentrum München, in collaboration with an international team, have identified a potential novel drug target for idiopathic pulmonary fibrosis, a dangerous chronic lung disease. They elucidated a ...
Jun 8, 2015
0
164